•Diagnosis: extraosseous/peripheral ameloblastoma
•10% of all amelob;astomas, occur in wide age range 9-92
•Molecular changes: similar to central ameloblastomas, MAPK signaling pathway mutation is common, with BRAFp.V600E being the most common mutation.
•Ddx: intraoral basal cell carcinoma and squamous cell carcinoma.
•Clinical: more indolent than conventional/central ameloblastoma, recurrence rate 9-20%
Comentários